NO20054418L - Substituted benzoylureidopyridylpiperidine and pyrrolidinecarboxylic acid derivatives, their preparation and use - Google Patents

Substituted benzoylureidopyridylpiperidine and pyrrolidinecarboxylic acid derivatives, their preparation and use

Info

Publication number
NO20054418L
NO20054418L NO20054418A NO20054418A NO20054418L NO 20054418 L NO20054418 L NO 20054418L NO 20054418 A NO20054418 A NO 20054418A NO 20054418 A NO20054418 A NO 20054418A NO 20054418 L NO20054418 L NO 20054418L
Authority
NO
Norway
Prior art keywords
substituted
acid derivatives
benzoylureidopyridylpiperidine
preparation
pyrrolidinecarboxylic acid
Prior art date
Application number
NO20054418A
Other languages
Norwegian (no)
Inventor
Andreas Herling
Elisabeth Defossa
Karl Schoenafinger
Thomas Klabunde
Dieter Kadereit
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20054418L publication Critical patent/NO20054418L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to substituted benzoylureidopyridyl-piperidine and -pyrrolidine carboxylic acid derivatives, to a method for the production thereof, and to their use. The invention concerns both compounds of formula (I), wherein the radicals have the cited meanings, as well as physiologically compatible salts of said compounds. These compounds are suited for use as, e.g. medicaments for preventing and treating Type 2 diabetes.
NO20054418A 2003-03-07 2005-09-23 Substituted benzoylureidopyridylpiperidine and pyrrolidinecarboxylic acid derivatives, their preparation and use NO20054418L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10309929A DE10309929B4 (en) 2003-03-07 2003-03-07 Substituted benzoylureidopyridyl-piperidine and -pyrrolidine-carboxylic acid derivatives, process for their preparation and their use
PCT/EP2004/001735 WO2004078743A1 (en) 2003-03-07 2004-02-21 Substituted benzoylureidopyridyl-piperidine and -pyrrolidine carboxylic acid derivatives, method for the production thereof and the use thereof

Publications (1)

Publication Number Publication Date
NO20054418L true NO20054418L (en) 2005-09-23

Family

ID=32945839

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054418A NO20054418L (en) 2003-03-07 2005-09-23 Substituted benzoylureidopyridylpiperidine and pyrrolidinecarboxylic acid derivatives, their preparation and use

Country Status (18)

Country Link
EP (1) EP1603895B1 (en)
JP (1) JP2006519795A (en)
KR (1) KR20050108487A (en)
CN (1) CN1759109A (en)
AT (1) ATE386735T1 (en)
AU (1) AU2004218267A1 (en)
BR (1) BRPI0408148A (en)
CA (1) CA2518322A1 (en)
CO (1) CO5690587A2 (en)
DE (2) DE10309929B4 (en)
HR (1) HRP20050779A2 (en)
MA (1) MA27745A1 (en)
MX (1) MXPA05009122A (en)
NO (1) NO20054418L (en)
PL (1) PL377293A1 (en)
RU (1) RU2005131011A (en)
WO (1) WO2004078743A1 (en)
ZA (1) ZA200506119B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006055462A1 (en) 2004-11-15 2006-05-26 Bristol-Myers Squibb Company 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
US7223786B2 (en) 2004-11-15 2007-05-29 Bristol-Myers Squibb Company 2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors
WO2006053274A2 (en) 2004-11-15 2006-05-18 Bristol-Myers Squibb Company 2-amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
WO2006055463A2 (en) 2004-11-15 2006-05-26 Bristol-Myers Squibb Company 2-amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
PE20110235A1 (en) 2006-05-04 2011-04-14 Boehringer Ingelheim Int PHARMACEUTICAL COMBINATIONS INCLUDING LINAGLIPTIN AND METMORPHINE
KR20120104534A (en) * 2009-10-06 2012-09-21 브리스톨-마이어스 스큅 컴퍼니 Pyrrolidine gpr40 modulators

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034004A1 (en) * 1980-09-10 1982-04-22 Hoechst Ag, 6000 Frankfurt SULFONYL UREAS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS AND THEIR USE
SK17252002A3 (en) * 2000-06-09 2003-05-02 Aventis Pharma Deutschland Gmbh Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
DE10116768A1 (en) * 2001-04-04 2002-10-10 Aventis Pharma Gmbh Hypoglycemic medicaments useful for treating type II diabetes contain new or known N-aroyl-N'-phenyl-urea derivatives which are glycogen phosphorylase a inhibitors
PE20021091A1 (en) * 2001-05-25 2003-02-04 Aventis Pharma Gmbh DERIVATIVES OF PHENYLUREA SUBSTITUTED WITH CARBONAMIDE AND PROCEDURE FOR THEIR PREPARATION
DE10125567B4 (en) * 2001-05-25 2004-08-26 Aventis Pharma Deutschland Gmbh Carbonamide substituted phenylurea derivatives, process for their preparation and their use as medicines
IL164249A0 (en) * 2002-04-11 2005-12-18 Aventis Pharma Gmbh Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use
MXPA05000055A (en) * 2002-07-11 2005-04-08 Aventis Pharma Gmbh Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments.
DE50312261D1 (en) * 2002-07-12 2010-02-04 Sanofi Aventis Deutschland HETEROCYCLICALLY SUBSTITUTED BENZOYL HYDROGEN, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICAMENT

Also Published As

Publication number Publication date
RU2005131011A (en) 2006-05-10
CO5690587A2 (en) 2006-10-31
CN1759109A (en) 2006-04-12
MXPA05009122A (en) 2005-10-20
JP2006519795A (en) 2006-08-31
DE502004006253D1 (en) 2008-04-03
BRPI0408148A (en) 2006-03-01
CA2518322A1 (en) 2004-09-16
EP1603895A1 (en) 2005-12-14
EP1603895B1 (en) 2008-02-20
MA27745A1 (en) 2006-02-01
KR20050108487A (en) 2005-11-16
WO2004078743A1 (en) 2004-09-16
HRP20050779A2 (en) 2006-10-31
ATE386735T1 (en) 2008-03-15
DE10309929B4 (en) 2006-02-23
AU2004218267A1 (en) 2004-09-16
PL377293A1 (en) 2006-01-23
ZA200506119B (en) 2006-11-29
DE10309929A1 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
IL176914A0 (en) Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
TNSN06409A1 (en) Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
NO20050134L (en) Diphenyllazidide ions substituted with acid groups, process for their preparation, drugs containing these compounds and their use
NO20085068L (en) Phenylamino-benzoxazole-substituted carboxylic acids, process for their preparation and use thereof as medicaments
RS20050019A (en) Heterocyclically substituted benzoylureas,method for their production and their use as medicaments
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
NO20071577L (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory diseases
NO20070089L (en) DPP-IV inhibitors
IL176915A0 (en) Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
CY1111327T1 (en) Substituted cyclohexylacetic acid derivatives
NO20050270L (en) New compounds, their use and manufacture
NO20060718L (en) Substituted thiophones and their use
DK1745010T3 (en) Substituted cyclohexyl-1,4-diamine derivatives
NO20054418L (en) Substituted benzoylureidopyridylpiperidine and pyrrolidinecarboxylic acid derivatives, their preparation and use
DK1513800T3 (en) Benzoylureido-cinnamic acid derivatives, process for their use
NO20076000L (en) Amino acid derivatives
BRPI0517734A (en) 1 - [(6,7-substituted alkoxyquinoxalinyl) aminocarbonyl] -4- (hetero) arylpiperazine derivatives
ATE471312T1 (en) DIARYLTRIAZOLEMETHYLAMINE DERIVATIVES AND THEIR PRODUCTION AND THERAPEUTIC USE
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
MA27649A1 (en) CARBONYLAMINO SUBSTITUTED ACYLPHENYLUREA DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF.
TW200505892A (en) Substituted 3-(benzoylureido)thiophene derivatives, processes for preparing them and their use
ATE458721T1 (en) IMINOSIC ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES
DK1406865T3 (en) succinic acid derivatives
DE60315597D1 (en) HALOACETAMIDOBENZOIC ACID DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PARASITIC ILLNESSES
TNSN05008A1 (en) Heterocyclically substituted benzoylureas, method for their production and their use as medicaments.